EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

DA-DRD5 signaling reprograms B cells to promote CD8+ T cell-mediated antitumor immunity

Yuqing Wu, Lei Zhu, Sheng Li, Lu Liu, Yaman Wang, Yongbing Yang, Yuan Mu, Qiuying Zhu, Yuying Jiang, Chunyan Wu, Peiwen Xi, Chunmei Ma und 5 weitere

Cell Reports · 2025

DOI: 10.1016/j.celrep.2025.115364 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2025. Verfasst von Yuqing Wu und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China; Branch of National Clinical Re…. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, Signal Transduction, B-Lymphocytes, Dopamine. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Fundamental Research Funds for the Central Universities, China Postdoctoral Science Foundation, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CD8-Positive T-LymphocytesSignal TransductionB-LymphocytesDopamineReceptors, Dopamine D5NeoplasmsAnimalsMiceMice, Inbred C57BLHumansLymphocyte ActivationJanus Kinase 1STAT1 Transcription Factor

Stichwörter der Autor:innen

B cellCP: CancerCP: Immunologyantitumor immunitydopaminedopamine receptor 5

Substanzen

DopamineReceptors, Dopamine D5Janus Kinase 1STAT1 Transcription Factor

Autor:innen und Institutionen

  • Department of Laboratory Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China; Branch of National Clinical Research Center for Laboratory Medicine, Nanjing 210029, China.
  • Jiangsu Breast Disease Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210036, China; Department of Breast Surgery, Women's Hospital of Nanjing Medical University (Nanjing Women and Children…
  • Department of Clinical Laboratory, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai 200120, China.
  • Department of Immunology, Nanjing Medical University, Nanjing 211166, China.
  • Department of Medical Laboratory, Affiliated Children's Hospital of Jiangnan University, Wuxi 214000, China.
  • The First Clinical School of Nanjing Medical University, Nanjing 210029, China.

Förderung

  • Fundamental Research Funds for the Central Universities
  • China Postdoctoral Science Foundation
  • National Natural Science Foundation of China
  • Nanjing Medical University
  • Soochow University

Zitieren

APA

Wu, Y., Zhu, L., Li, S., Liu, L., Wang, Y., Yang, Y., Mu, Y., Zhu, Q., Jiang, Y., Wu, C., Xi, P., Ma, C., Liang, L., Gao, M., Hu, Y., Ding, Q., & Pan, S. (2025). DA-DRD5 signaling reprograms B cells to promote CD8+ T cell-mediated antitumor immunity. Cell Reports. https://doi.org/10.1016/j.celrep.2025.115364

Vancouver

Wu Y, Zhu L, Li S, Liu L, Wang Y, Yang Y, et al. DA-DRD5 signaling reprograms B cells to promote CD8+ T cell-mediated antitumor immunity. Cell Reports. 2025. doi:10.1016/j.celrep.2025.115364

BibTeX
@article{Wu2025,
  author = {Wu, Yuqing and Zhu, Lei and Li, Sheng and Liu, Lu and Wang, Yaman and Yang, Yongbing and Mu, Yuan and Zhu, Qiuying and Jiang, Yuying and Wu, Chunyan and Xi, Peiwen and Ma, Chunmei and Liang, Lijun and Gao, Min and Hu, Yingchao and Ding, Qiang and Pan, Shiyang},
  title = {DA-DRD5 signaling reprograms B cells to promote CD8+ T cell-mediated antitumor immunity},
  journal = {Cell Reports},
  year = {2025},
  doi = {10.1016/j.celrep.2025.115364}
}
Kostenlos starten →